178 related articles for article (PubMed ID: 37885996)
1. Preparation and characterization of tamoxifen loaded silica and NH2 functionalized mesoporous silica nanoparticles as delivery systems against MCF-7 breast cancer cells.
Taghavi S; Shahnani M; Rafati H
Iran J Basic Med Sci; 2023; 26(11):1334-1341. PubMed ID: 37885996
[TBL] [Abstract][Full Text] [Related]
2. Tamoxifen loaded folic acid armed PEGylated magnetic nanoparticles for targeted imaging and therapy of cancer.
Heidari Majd M; Asgari D; Barar J; Valizadeh H; Kafil V; Abadpour A; Moumivand E; Mojarrad JS; Rashidi MR; Coukos G; Omidi Y
Colloids Surf B Biointerfaces; 2013 Jun; 106():117-25. PubMed ID: 23434700
[TBL] [Abstract][Full Text] [Related]
3.
Mohebian Z; Babazadeh M; Zarghami N
Adv Pharm Bull; 2023 Mar; 13(2):317-327. PubMed ID: 37342377
[No Abstract] [Full Text] [Related]
4. Functionalized silica nanoparticles as a carrier for Betamethasone Sodium Phosphate: Drug release study and statistical optimization of drug loading by response surface method.
Ghasemnejad M; Ahmadi E; Mohamadnia Z; Doustgani A; Hashemikia S
Mater Sci Eng C Mater Biol Appl; 2015 Nov; 56():223-32. PubMed ID: 26249584
[TBL] [Abstract][Full Text] [Related]
5. Curcumin-loaded guanidine functionalized PEGylated I3ad mesoporous silica nanoparticles KIT-6: practical strategy for the breast cancer therapy.
Ma'mani L; Nikzad S; Kheiri-Manjili H; Al-Musawi S; Saeedi M; Askarlou S; Foroumadi A; Shafiee A
Eur J Med Chem; 2014 Aug; 83():646-54. PubMed ID: 25014638
[TBL] [Abstract][Full Text] [Related]
6. High efficacy of tamoxifen-loaded L-lysine coated magnetic iron oxide nanoparticles in cell cycle arrest and anti-cancer activity for breast cancer therapy.
Rostami S; Tafvizi F; Kheiri Manjili HR
Bioimpacts; 2022; 12(4):301-313. PubMed ID: 35975200
[No Abstract] [Full Text] [Related]
7. Erratum: Preparation of Poly(pentafluorophenyl acrylate) Functionalized SiO2 Beads for Protein Purification.
J Vis Exp; 2019 Apr; (146):. PubMed ID: 31038480
[TBL] [Abstract][Full Text] [Related]
8. Impact of the mesoporous silica SBA-15 functionalization on the mode of action of Ph
Edeler D; Drača D; Petković V; Natalio F; Maksimović-Ivanić D; Mijatović S; Schmidt H; Kaluđerović GN
Mater Sci Eng C Mater Biol Appl; 2019 Jul; 100():315-322. PubMed ID: 30948067
[TBL] [Abstract][Full Text] [Related]
9. Modifying release of poorly soluble active pharmaceutical ingredients with the amine functionalized SBA-16 type mesoporous materials.
Jadach B; Feliczak-Guzik A; Nowak I; Milanowski B; Piotrowska-Kempisty H; Murias M; Lulek J
J Biomater Appl; 2019 Apr; 33(9):1214-1231. PubMed ID: 30791849
[TBL] [Abstract][Full Text] [Related]
10. Adsorption and release of ampicillin antibiotic from ordered mesoporous silica.
Nairi V; Medda L; Monduzzi M; Salis A
J Colloid Interface Sci; 2017 Jul; 497():217-225. PubMed ID: 28285049
[TBL] [Abstract][Full Text] [Related]
11. Adsorption and Release Properties of Drug Delivery System Naproxen-SBA-15: Effect of Surface Polarity, Sodium/Acid Drug Form and
Zauška Ľ; Beňová E; Urbanová M; Brus J; Zeleňák V; Hornebecq V; Almáši M
J Funct Biomater; 2022 Dec; 13(4):. PubMed ID: 36547535
[TBL] [Abstract][Full Text] [Related]
12. Folate-targeted nanoparticles based on albumin and albumin/alginate mixtures as controlled release systems of tamoxifen: synthesis and in vitro characterization.
Martínez A; Olmo R; Iglesias I; Teijón JM; Blanco MD
Pharm Res; 2014 Jan; 31(1):182-93. PubMed ID: 23921489
[TBL] [Abstract][Full Text] [Related]
13. Hyaluronic acid-coated chitosan nanoparticles as targeted-carrier of tamoxifen against MCF7 and TMX-resistant MCF7 cells.
Nokhodi F; Nekoei M; Goodarzi MT
J Mater Sci Mater Med; 2022 Feb; 33(2):24. PubMed ID: 35157166
[TBL] [Abstract][Full Text] [Related]
14. Resveratrol Encapsulation and Release from Pristine and Functionalized Mesoporous Silica Carriers.
Ioniţă S; Lincu D; Mitran RA; Ziko L; Sedky NK; Deaconu M; Brezoiu AM; Matei C; Berger D
Pharmaceutics; 2022 Jan; 14(1):. PubMed ID: 35057098
[TBL] [Abstract][Full Text] [Related]
15. pH-responsive gelatin polymer-coated silica-based mesoporous composites for the sustained-release of indomethacin.
Yu B; Shi R; Liu C; Liu Z; Shen P; Hu J; Shi F
Heliyon; 2023 Mar; 9(3):e13705. PubMed ID: 36873513
[TBL] [Abstract][Full Text] [Related]
16. Modification of the Release of Poorly Soluble Sulindac with the APTES-Modified SBA-15 Mesoporous Silica.
Dadej A; Woźniak-Braszak A; Bilski P; Piotrowska-Kempisty H; Józkowiak M; Geszke-Moritz M; Moritz M; Dadej D; Jelińska A
Pharmaceutics; 2021 Oct; 13(10):. PubMed ID: 34683986
[TBL] [Abstract][Full Text] [Related]
17. Effective cellular internalization, cell cycle arrest and improved pharmacokinetics of Tamoxifen by cholesterol based lipopolymeric nanoparticles.
Mazumdar S; Italiya KS; Sharma S; Chitkara D; Mittal A
Int J Pharm; 2018 May; 543(1-2):96-106. PubMed ID: 29578081
[TBL] [Abstract][Full Text] [Related]
18. Preparation and in-vitro evaluation of mesoporous biogenic silica nanoparticles obtained from rice and wheat husk as a biocompatible carrier for anti-cancer drug delivery.
Porrang S; Rahemi N; Davaran S; Mahdavi M; Hassanzadeh B
Eur J Pharm Sci; 2021 Aug; 163():105866. PubMed ID: 33957220
[TBL] [Abstract][Full Text] [Related]
19. Formulation and evaluation of hyaluronic acid-based mucoadhesive self nanoemulsifying drug delivery system (SNEDDS) of tamoxifen for targeting breast cancer.
Batool A; Arshad R; Razzaq S; Nousheen K; Kiani MH; Shahnaz G
Int J Biol Macromol; 2020 Jun; 152():503-515. PubMed ID: 32112841
[TBL] [Abstract][Full Text] [Related]
20. Carboxyl-functionalized mesoporous silica nanoparticles for the controlled delivery of poorly water-soluble non-steroidal anti-inflammatory drugs.
Gou K; Wang Y; Guo X; Wang Y; Bian Y; Zhao H; Guo Y; Pang Y; Xie L; Li S; Li H
Acta Biomater; 2021 Oct; 134():576-592. PubMed ID: 34280558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
